The authors are in the Tuberculosis Research Section, National Institute of Allergy and Infectious Disease, National Institutes of Health, Rockville, Maryland 20852, USA. cbarry@niaid.nih.gov
Mycobacterium tuberculosis adapts to the low-glucose conditions in its host by using lipids as a fuel source. This adaptation reveals a weak flank that might be exploited in drug development, as shown in work on mice and human cells (pages 638−644).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
